Cargando…

ASCL2 Affects the Efficacy of Immunotherapy in Colon Adenocarcinoma Based on Single-Cell RNA Sequencing Analysis

Colon adenocarcinoma (COAD) is one of the leading causes of cancer-associated deaths worldwide. Patients with microsatellite instability-high (MSI-H) tumors were shown to highly benefit from immune checkpoint inhibitors (ICIs) than patients with microsatellite stable (MSS) tumors. Furthermore, the i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Lei, Sun, Shengnan, Qu, Fei, Liu, Xiuxiu, Sun, Meili, Pan, Ying, Zheng, Yan, Su, Guohai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9237783/ https://www.ncbi.nlm.nih.gov/pubmed/35774798 http://dx.doi.org/10.3389/fimmu.2022.829640

Ejemplares similares

Classification of colon adenocarcinoma based on immunological characterizations: Implications for prognosis and immunotherapy
por: Xu, Midie, et al.
Publicado: (2022)

Comprehensive analysis of the prognosis, tumor microenvironment, and immunotherapy response of SDHs in colon adenocarcinoma
por: Nan, Han, et al.
Publicado: (2023)

Analysis of Interleukin-1 Signaling Alterations of Colon Adenocarcinoma Identified Implications for Immunotherapy
por: Zhou, Xiaogang, et al.
Publicado: (2021)

Immunotherapy efficacy predictive tool for lung adenocarcinoma based on neural network
por: Li, Wei, et al.
Publicado: (2023)

Aging-related features predict prognosis and immunotherapy efficacy in hepatocellular carcinoma
por: Hong, Ting, et al.
Publicado: (2022)

Prediction of prognosis, immunogenicity and efficacy of immunotherapy based on glutamine metabolism in lung adenocarcinoma
por: Liu, Jichang, et al.
Publicado: (2022)

Efficacy and safety of innate and adaptive immunotherapy combined with standard of care in high-grade gliomas: a systematic review and meta-analysis
por: Guo, Baofeng, et al.
Publicado: (2023)

The future of combination immunotherapy in oesophageal adenocarcinoma
por: Davern, Maria, et al.
Publicado: (2023)

Identification of immune activation-related gene signature for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma
por: Zeng, Weibiao, et al.
Publicado: (2023)

The N terminus of Ascl1 underlies differing proneural activity of mouse and Xenopus Ascl1 proteins
por: Hardwick, Laura J.A., et al.
Publicado: (2018)

Identification of microsatellite instability and immune-related prognostic biomarkers in colon adenocarcinoma
por: Sun, Ziquan, et al.
Publicado: (2022)

Identification and validation of a muscle failure index to predict prognosis and immunotherapy in lung adenocarcinoma through integrated analysis of bulk and single-cell RNA sequencing data
por: Gu, Xuyu, et al.
Publicado: (2023)

EGFR mediates activation of RET in lung adenocarcinoma with neuroendocrine differentiation characterized by ASCL1 expression
por: Bhinge, Kaustubh, et al.
Publicado: (2017)

Intestinal Stem Cell Marker ASCL2 is a Novel Prognostic Predictor in Esophageal Adenocarcinoma
por: Shibahara, Yukiko, et al.
Publicado: (2022)

Identification of a Novel Immune Landscape Signature for Predicting Prognosis and Response of Colon Cancer to Immunotherapy
por: Wang, Zheng, et al.
Publicado: (2022)

Mechanisms Governing Immunotherapy Resistance in Pancreatic Ductal Adenocarcinoma
por: Schmiechen, Zoe C., et al.
Publicado: (2021)

Predictive biomarkers of colon cancer immunotherapy: Present and future
por: Hou, Wanting, et al.
Publicado: (2022)

A robust CD8(+) T cell-related classifier for predicting the prognosis and efficacy of immunotherapy in stage III lung adenocarcinoma
por: Feng, Jinteng, et al.
Publicado: (2022)

Immunotherapy with STING and TLR9 agonists promotes synergistic therapeutic efficacy with suppressed cancer-associated fibroblasts in colon carcinoma
por: Hajiabadi, Sare, et al.
Publicado: (2023)

Characterization of m(6)A RNA Methylation Regulators Predicts Survival and Immunotherapy in Lung Adenocarcinoma
por: Zhu, Minggao, et al.
Publicado: (2021)

Co-Mutation of FAT3 and LRP1B in Lung Adenocarcinoma Defines a Unique Subset Correlated With the Efficacy of Immunotherapy
por: Zhu, Mingyu, et al.
Publicado: (2022)

Signatures of Multi-Omics Reveal Distinct Tumor Immune Microenvironment Contributing to Immunotherapy in Lung Adenocarcinoma
por: Huang, Ziqi, et al.
Publicado: (2021)

SIRGs score may be a predictor of prognosis and immunotherapy response for esophagogastric junction adenocarcinoma
por: OuYang, Li-Ying, et al.
Publicado: (2022)

Ascl2 Knockdown Results in Tumor Growth Arrest by miRNA-302b-Related Inhibition of Colon Cancer Progenitor Cells
por: Zhu, Rong, et al.
Publicado: (2012)

Deciphering the role of QPCTL in glioma progression and cancer immunotherapy
por: Liu, Yu’e, et al.
Publicado: (2023)

Evaluation of immunotherapy efficacy in gynecologic cancer
por: Jiang, Genyi, et al.
Publicado: (2023)

Identifying a lactic acid metabolism-related gene signature contributes to predicting prognosis, immunotherapy efficacy, and tumor microenvironment of lung adenocarcinoma
por: Zhao, Fangchao , et al.
Publicado: (2022)

Identification and verification of the prognostic value of CUL7 in colon adenocarcinoma
por: Wang, Chengxing, et al.
Publicado: (2022)

Identification and Validation of a Novel Signature Based on NK Cell Marker Genes to Predict Prognosis and Immunotherapy Response in Lung Adenocarcinoma by Integrated Analysis of Single-Cell and Bulk RNA-Sequencing
por: Song, Peng, et al.
Publicado: (2022)

Combinatory local ablation and immunotherapies for hepatocellular carcinoma: Rationale, efficacy, and perspective
por: Chen, Shuling, et al.
Publicado: (2022)

Subcellular localisation modulates ubiquitylation and degradation of Ascl1
por: Gillotin, Sébastien, et al.
Publicado: (2018)

Ascl2 activation by YAP1/KLF5 ensures the self-renewability of colon cancer progenitor cells
por: Wei, Xiaolong, et al.
Publicado: (2017)

Transcriptional patterns reveal tumor histologic heterogeneity and immunotherapy response in lung adenocarcinoma
por: Jiao, Mengxue, et al.
Publicado: (2022)

Immunotherapy for Pediatric Acute Lymphoblastic Leukemia: Recent Advances and Future Perspectives
por: Lv, Meng, et al.
Publicado: (2022)

Stemness Subtypes and Scoring System Predict Prognosis and Efficacy of Immunotherapy in Soft Tissue Sarcoma
por: Gu, Hui-Yun, et al.
Publicado: (2022)

Behavioral factors to modulate immunotherapy efficacy in cancer
por: Jongerius, C., et al.
Publicado: (2022)

Valproic acid silencing of ascl1b/Ascl1 results in the failure of serotonergic differentiation in a zebrafish model of fetal valproate syndrome
por: Jacob, John, et al.
Publicado: (2014)

Inhibition of Glioma Development by ASCL1-Mediated Direct Neuronal Reprogramming
por: Cheng, Xueyan, et al.
Publicado: (2019)

Molecular Mechanisms Underlying Ascl1-Mediated Astrocyte-to-Neuron Conversion
por: Rao, Zhiping, et al.
Publicado: (2021)

TNFα-induced Up-regulation of Ascl2 Affects the Differentiation and Proliferation of Neural Stem Cells
por: Liu, Zhongfeng, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_a3rrark6d2pbd6t8q870ju5oji